Perspective Therapeutics (CATX) Shares Outstanding (Diluted) (2023 - 2026)
Perspective Therapeutics (CATX) recorded Shares Outstanding (Diluted) of 120.65 million in Q2 2026, up 62.5% from 74.24 million a year earlier and up 16.5% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, Perspective Therapeutics reported Shares Outstanding (Diluted) of 73.81 million, up 14.6% from FY2024.
- Across earlier years, Shares Outstanding (Diluted) came in at 64.43 million in FY2024 (+140.7%) and 26.76 million in FY2023.
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2023.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for ten consecutive quarters, with growth averaging 59.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 5.2% (Q3 2025) to 151.8% (Q3 2024).
- Per Business Quant, the preceding three quarters came in at 103.6 million (Q1 2026), 73.81 million (Q4 2025) and 74.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Perspective Therapeutics | 312.60 Mn | 312.60 Mn | - | 120.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.65 Mn |
| Mar 31, 2026 | 103.60 Mn |
| Dec 31, 2025 | 73.81 Mn |
| Sep 30, 2025 | 74.30 Mn |
| Jun 30, 2025 | 74.24 Mn |
| Mar 31, 2025 | 72.36 Mn |
| Dec 31, 2024 | 64.43 Mn |
| Sep 30, 2024 | 70.63 Mn |
| Jun 30, 2024 | 66.65 Mn |
| Mar 31, 2024 | 49.51 Mn |
| Dec 31, 2023 | 26.76 Mn |
| Sep 30, 2023 | 28.06 Mn |
| Jun 30, 2023 | 28.00 Mn |
| Mar 31, 2023 | 22.86 Mn |
API Access
Perspective Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();